Thursday, March 30, 2017
Andrew Casey is president and CEO BIOTECanada.
Industry and governments need to continue identifying gaps and working together to ensure Canada’s policy environment is as strategic and comprehensive as it needs to be.
Canadians suffering from rare diseases will benefit, as they will no longer be left out of the system of care.
Sent to you every weekday morning. SIGN UP.
© 2017 Hill Times Publishing |
Contact Us |
Work with Us |